- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Latest Conference Articles
The OncLive® Conference page includes a listing of all conferences covered by OncLive®, including the ASCO, ESMO, SITC, EHA, ASH, and SABCS annual meetings, as well as the Chemotherapy Foundation Symposium and Miami Breast Cancer Conference, among many others. Conference coverage incorporates articles and interviews in written and video format.
Dr. Gomella on the Unique Attributes of Neoadjuvant Zytiga
May 30th 2012, 10:06am
Dr. Leonard Gomella, from Jefferson Kimmel Cancer Center, on the Unique Attributes of Neoadjuvant Zytiga.
Dr. Ladenson on Diagnosis of Thyroid Nodules
May 29th 2012, 12:09pm
AACE Annual Scientific and Clinical Congress
Dr. Paul W. Ladenson, from Johns Hopkins Medicine, on Diagnosis of Thyroid Nodules
Carriers of Mutation Responsible for Multiple Endocrine Neoplasia Can Face Difficult Choices
May 29th 2012, 6:42am
AACE Annual Scientific and Clinical Congress
Results of a multi-generational case study strengthen the case for genetic screening in cases of hereditary thyroid cancer.
Researchers Find Regional Differences in Stage of Presentation and Survival of Individuals With Thyroid Cancer
May 29th 2012, 6:38am
AACE Annual Scientific and Clinical Congress
Patients are more likely to present with regional or distant metastases and experience lower rates of cancer-free survival depending on where they live.
Genetic Data Points to Potential New Therapeutic Target for Adrenocortical Carcinoma
May 29th 2012, 6:28am
AACE Annual Scientific and Clinical Congress
Researchers find that overexpression of a specific gene is associated with poor survival in patients with adrenocortical carcinoma.
Why Medical Tattoos Shouldn't Be Taboo
May 25th 2012, 9:33am
AACE Annual Scientific and Clinical Congress
Another presentation at the AACE meeting on Thursday featured Dr. Saleh Aldasouqi, FACE, ECNU, discussing a topic that is not heard about too often in the medical world: tattoos.
Telemedicine a Valuable Way to Deliver Healthcare
May 24th 2012, 1:21pm
AACE Annual Scientific and Clinical Congress
Patients who live far from medical facilities benefit from having "virtual" conversations with their doctors and are comfortable with that arrangement.
AACE 21st Annual Scientific and Clinical Congress Slideshow
May 24th 2012, 1:20pm
AACE Annual Scientific and Clinical Congress
Photos taken from the AACE 21st Annual Scientific and Clinical Congress held at the Pennsylvania Convention Center, from May 23-27, 2012.
Oncology Posters Presented at Annual Endocrinology Meeting
May 24th 2012, 12:48pm
AACE Annual Scientific and Clinical Congress
A look at two poster presentations from the AACE meeting focusing on insular carcinoma and medullary thyroid cancer.
Dr. Rotkowitz on the Dabrafenib/Trametinib Combination
May 17th 2012, 1:45pm
Dr. Michael Rotkowitz, from Cancer Treatment Centers of America, on the Dabrafenib Plus Trametinib Combination for Melanoma
Neoadjuvant Zytiga Helps Eliminate Some Patients' Prostate Tumors
May 16th 2012, 2:06pm
Combined neoadjuvant treatment with abiraterone acetate (Zytiga) plus standard hormonal therapy before prostatectomy eradicated or nearly eradicated tumors in 34% of patients with localized high-risk prostate cancer.
Combining Two Targeted Therapies Stalls Disease Progression in Melanoma Patients With BRAF Mutations
May 16th 2012, 2:05pm
A combination of the BRAF inhibitor dabrafenib and the MEK inhibitor trametinib has shown promising activity in patients with advanced melanoma.
Olanzapine Proves Effective in Breakthrough CINV
May 16th 2012, 2:04pm
Olanzapine, an antipsychotic medication that is often used off-label, has proved highly effective in controlling breakthrough chemotherapy-induced nausea and vomiting.
Dr. Gomella on Neoadjuvant Hormonal Therapy Plus Zytiga
May 16th 2012, 2:04pm
Dr. Leonard Gomella, from Jefferson Kimmel Cancer Center, on Neoadjuvant Hormonal Therapy Combined With Abiraterone Acetate
Dr. Chapman on BRAF/MEK Combination for Melanoma
May 16th 2012, 2:02pm
Dr. Paul Chapman, from Memorial Sloan-Kettering Cancer Center, on Combining BRAF and MEK Inhibitors for Advanced Melanoma
Dr. Markman on PCP Awareness of Long-Term Side Effects
May 16th 2012, 2:01pm
Dr. Maurie Markman, Cancer Treatment Centers of America, on Primary Care Physician Awareness of Long-Term Chemotherapy Side Effects
PCPs Highly Unaware of Long-Term Chemotherapy Side Effects
May 16th 2012, 2:01pm
Many primary care providers and some oncologists are unaware of the long-term effects of four chemotherapy drugs used to treat two of the most common forms of cancer.
Dr. Goy on Crizotinib for Pediatric Patients With ALCL
May 16th 2012, 2:00pm
Dr. Andre Goy, from John Theurer Cancer Center, on Crizotinib for Pediatric Patients With ALCL
Crizotinib Active in ALK-Positive Pediatric Cancers
May 16th 2012, 2:00pm
Targeting the ALK gene with the oral agent crizotinib slowed or eliminated signs of tumor growth in pediatric patients with aggressive forms of neuroblastoma, ALCL, and IMTs.
Dr. Kazmi Discusses Olanzapine for Breakthrough CINV
May 16th 2012, 12:02pm
Dr. Shayma Kazmi, from Cancer Treatment Centers of America, on Olanzapine for Breakthrough Chemotherapy-Induced Nausea and Vomiting